skip to Main Content

Ri.MED Research Seminar on Engineering Immunity for Tissue Regeneration: from bench to clinic and back by Anthal Smits, PhD

The eigth 2026 Ri.MED Research Seminar will take place on Thursday December 3, 2026 at 9:30 am in Aula Pagliaro, ISMETT – Palermo.

Attendance is free, but registration is required.

The Seminar will only be held in person (NOT online).

Scientific Host:
Prof. Antonio D’Amore, PhD

Engineering Immunity for Tissue Regeneration: from bench to clinic and back
by Anthal Smits, PhD
Associate Professor, Lead of ImmunoRegeneration Group
Dept of Biomedical Engineeering, Institute for Complex Molecular Systems at Eindhoven University of Technology, Eindhoven (NL)

ABSTRACT: The host immune response to a medical device can be harmful, leading to fibrotic encapsulation and implant failure. Yet this same response is the body’s natural kick-starter for tissue regeneration after injury. Our aim is to develop implants that promote regeneration in situ by steering the host immune response toward pro-regenerative pathways. Using this approach, we have developed resorbable synthetic heart valve and blood vessel replacements. After implantation, these materials trigger an inflammatory response that supports new tissue formation as the implants gradually resorb.
This seminar will trace our journey from preclinical studies to ongoing clinical trials of regenerative pulmonary valves, arteriovenous conduits, and endovascular stents. I will discuss how successes and failures have revealed key challenges to robust clinical application. Our current research investigates the spatiotemporal patterns of inflammation during in situ regeneration and how these patterns may vary among patients. In particular, we study the mechanobiology of macrophages and foreign body giant cells, as well as their interactions with tissue-producing cells and the transient inflammatory niche created by the implant. This knowledge could inform the design of next-generation implants with more predictable and tuneable inflammatory and regenerative responses.

BIOSKETCH: Anthal Smits is Associate Professor of ImmunoRegeneration in the Department of Biomedical Engineering and the Institute for Complex Molecular Systems (ICMS) at Eindhoven University of Technology, The Netherlands. He leads the ImmunoRegeneration Group, which studies how the immune system can be steered to enable in situ tissue regeneration using resorbable biomaterials. The group focuses particularly on macrophages and foreign body giant cells, aiming to understand and control inflammation to promote functional tissue repair.
To achieve this, the group combines advanced human in vitro and in silico models of inflammation with in vivo studies to enable rational implant design. While the primary clinical applications are cardiovascular therapies, including heart valves and blood vessels, the research is curiosity-driven and broadly applicable. Dr. Smits’ work contributed to the world’s first clinical trials of regenerative heart valves for paediatric patients.
The group’s research spans tissue engineering, immunology and mechanobiology. In 2021, Dr. Smits received an ERC Starting Grant for the MACxercise project on macrophage mechanobiology. He is a faculty member in major Dutch research programs, including Materials-Driven Regeneration and DRIVE-RM, which investigate patient variability in biomaterial-driven regeneration. Since 2022, he is an elected board member of the Netherlands Society for Biomaterials and Tissue Engineering.

For info: communication@fondazionerimed.com

DOWNLOAD THE FLYER

Enter your data


Privacy

INFORMATION ART. 13 LAW 196/2003 \n The personal data provided at the time of registration will be subject to computerized and manual processing, in order to document your participation and for the treatments deriving from legal obligations. They could be communicated to service providers related to the event for the completion of the practices relating to the organization of the event, as well as to the competent authorities according to the legal provisions. The provision of such data is mandatory and essential for participation in the training event. The data controller is the Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, in the person of its legal representative, to whom all the rights provided for in art. 7 with the limitations of art. 8 of law 196/2003.

Back To Top